1983
DOI: 10.1016/0162-3109(83)90048-6
|View full text |Cite
|
Sign up to set email alerts
|

Effects of treatment with muramyl dipeptide on resistance to Mycobacterium leprae and Mycobacterium marinum infection in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

1985
1985
2018
2018

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 28 publications
0
4
0
Order By: Relevance
“…Interestingly, it has been reported that in vivo MDP treatment failed to induce resistance to Mycobacterium leprae and Mycobacterium marinum in mice (40). In addition, in vitro treatment of T cells with murabutide, an MDP analog, reversed T cell anergy to mycobacteria leprae antigens (41) suggesting that in vivo the inability to mount an effective response to muramyl dipeptide may play a role in the exacerbation of the infection.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, it has been reported that in vivo MDP treatment failed to induce resistance to Mycobacterium leprae and Mycobacterium marinum in mice (40). In addition, in vitro treatment of T cells with murabutide, an MDP analog, reversed T cell anergy to mycobacteria leprae antigens (41) suggesting that in vivo the inability to mount an effective response to muramyl dipeptide may play a role in the exacerbation of the infection.…”
Section: Discussionmentioning
confidence: 99%
“…The following bacterial challenges have been used: Salmonella typhimurium [21], Salmonella enteritidis [57], Streptococcus pneumoniae [35], Pseudonomas aeruginosa, and Listeria monocytogenes [28,53]. Moreover, the activity of MDP was measured vis-a-vis two parasitic agents, Toxoplasma cruzi [37] and Toxoplasma 9ondii [43], and against a fungal infection, Candida albicans [53]. In certain immunocompromised hosts challenged by antibiotics sensitive or resistant pathogens, MDP was also shown to be capable of inducing a good level of resistance to infection [58,59].…”
Section: Enhancement Of Nonspecific Resistance To Bacterial Viral Omentioning
confidence: 99%
“…difficult to interpret; it could be argued that the protection observed following intradermal administration of killed M. leprae is mediated by nonspecific macrophage activation leading to enhanced resistance rather than the induction of a specific T-cell response. Indeed, mice undergoing local graft-versus-host disease (10) or animals treated with Corynebacterium parvum (5) show enhanced resistance to M. leprae infection, presumably due to the nonspecific effects of enhanced macrophage activation. However, in the former case the resistance was manifested as a slight retardation of growth of M. leprae, and in the experiments with C. parvum inoculation of the C. parvum directly into the footpad significantly limited growth in the inoculated footpad but not in the contralateral footpad.…”
mentioning
confidence: 99%